Et al Phillip Frost MD - 06 Jun 2025 SCHEDULE 13D/A Report for NOCOPI TECHNOLOGIES INC/MD/ Common stock of the Company, par value $0.01 per share ("Common Shares") (NNUP)

Filing manager
Et al Phillip Frost MD
Reporting owner
Phillip Frost, M.D.
Security
NOCOPI TECHNOLOGIES INC/MD/ Common stock of the Company, par value $0.01 per share ("Common Shares")
Beneficially owned shares
1,467,782 shares
Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13D/A

Active or control-oriented beneficial ownership filing.

Ownership

14%

Beneficial ownership of this reported class.

Shares

1,467,782 shares

Shares beneficially owned as disclosed.

Event date

06 Jun 2025

Date tied to the ownership event or amendment.

Accepted by SEC

11 Jun 2025

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Class ownership
14%
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
NNUP
Shares outstanding
10,792,515 shares
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
SCHEDULE 13D/A
Accepted by SEC
11 Jun 2025, 19:40:39 UTC
Event date
06 Jun 2025
Source filing
View source filing

Key filing fact

Et al Phillip Frost MD disclosed 14% ownership in NOCOPI TECHNOLOGIES INC/MD/ Common stock of the Company, par value $0.01 per share ("Common Shares") (NNUP) on 06 Jun 2025.

Key facts

  • Et al Phillip Frost MD filed SCHEDULE 13D/A for NOCOPI TECHNOLOGIES INC/MD/ Common stock of the Company, par value $0.01 per share ("Common Shares") (NNUP).
  • Disclosed ownership: 14%.
  • Date of event: 06 Jun 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 11 Jun 2025, 19:40.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (2)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
Phillip Frost, M.D. 14% 1,467,782 0 1,467,782 /s/ Phillip Frost, M.D. Phillip Frost, M.D. 0000898860
Frost Gamma Investments Trust 14% 1,467,782 0 1,467,782 /s/ Phillip Frost, M.D. Phillip Frost, M.D., Trustee
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .